OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company, today announced its participation in the H.C...
OS Therapies Incorporated (NYSE American: OSTX) (“OS Therapies” or “the Company”), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company, today announced that the last...
OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company, today announced that it has appointed Borys...
OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company, today provided a clarification for market...
Focus of work at JLABS on tunable Antibody Drug Conjugate linker-based platform OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), an ADC and Immunotherapy research and...
OS Therapies Incorporated (“OS Therapies” or the “Company”) (NYSE-A: OSTX), a Cancer Immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced the formation of a...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.4599 | 12.3629032258 | 3.72 | 4.31 | 3.72 | 74333 | 4.07583928 | CS |
4 | 0.9499 | 29.4086687307 | 3.23 | 4.67 | 2.56 | 138697 | 3.79374942 | CS |
12 | 0.1799 | 4.4975 | 4 | 4.9 | 2.51 | 344969 | 3.83975742 | CS |
26 | 0.1799 | 4.4975 | 4 | 4.9 | 2.51 | 344969 | 3.83975742 | CS |
52 | 0.1799 | 4.4975 | 4 | 4.9 | 2.51 | 344969 | 3.83975742 | CS |
156 | 0.1799 | 4.4975 | 4 | 4.9 | 2.51 | 344969 | 3.83975742 | CS |
260 | 0.1799 | 4.4975 | 4 | 4.9 | 2.51 | 344969 | 3.83975742 | CS |
Symbole | Prix | Vol. |
---|---|---|
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 25,96 (-12,74%) | 156,14M |
SOXSDirexion Daily Semiconductor Bear 3X Shares New | US$ 30,83 (12,97%) | 83,31M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 8,07 (5,08%) | 74,84M |
SPYSPDR S&P 500 | US$ 540,36 (-1,68%) | 68,59M |
SHProShares Short S&P500 New | US$ 11,64 (1,66%) | 55,4M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales